Prenetics Global Appoints Experienced CFO for Rapidly Expanding IM8 Subsidiary

summarizeSummary

Prenetics Global's key growth subsidiary, IM8, has appointed Brian J. Rosin as its new Chief Financial Officer, bringing two decades of relevant financial leadership experience to support its rapid global expansion.

check_boxKey Events

• New CFO for IM8 Subsidiary

  Brian J. Rosin has been appointed as the Chief Financial Officer of IM8, Prenetics Global's premium health and longevity brand.

• Experienced Financial Leader

  Mr. Rosin brings nearly two decades of financial leadership experience in consumer e-commerce, premium wellness, and subscription brands, with a focus on scaling operations and unit economics.

• Supports Rapid Global Expansion

  The appointment establishes dedicated finance leadership for IM8 to support its rapid global expansion across more than 40 countries and its projected $190 million to $210 million in revenue for full year 2026.

auto_awesomeAnalysis

Prenetics Global has appointed Brian J. Rosin as the Chief Financial Officer for its IM8 subsidiary. This is a significant hire given IM8's rapid global expansion and its projected revenue of $190 million to $210 million for 2026, making it a core growth driver for the parent company. Mr. Rosin's extensive background in consumer e-commerce and premium wellness brands is crucial for scaling IM8's financial operations and ensuring disciplined growth.